News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
620,826 Results
Type
Article (44402)
Company Profile (344)
Press Release (576069)
Multimedia
Podcasts (109)
Webinars (16)
Section
Business (168532)
Career Advice (2464)
Deals (30515)
Drug Delivery (120)
Drug Development (79204)
Employer Resources (148)
FDA (14692)
Job Trends (13084)
News (297819)
Policy (28761)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2691)
Academic (1)
Accelerated approval (32)
Adcomms (31)
Allergies (140)
Alliances (43139)
ALS (178)
Alzheimer's disease (1733)
Antibody-drug conjugate (ADC) (331)
Approvals (14911)
Artificial intelligence (511)
Autoimmune disease (147)
Automation (34)
Bankruptcy (327)
Best Places to Work (10684)
BIOSECURE Act (17)
Biosimilars (178)
Biotechnology (258)
Bladder cancer (159)
Brain cancer (59)
Breast cancer (635)
Cancer (4821)
Cardiovascular disease (413)
Career advice (2091)
Career pathing (38)
CAR-T (289)
CDC (43)
Cell therapy (766)
Cervical cancer (31)
Clinical research (67475)
Collaboration (1684)
Company closure (4)
Compensation (837)
Complete response letters (65)
COVID-19 (2688)
CRISPR (97)
C-suite (859)
Cystic fibrosis (148)
Data (6165)
Decentralized trials (2)
Denatured (23)
Depression (144)
Diabetes (495)
Diagnostics (6124)
Digital health (36)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (254)
Drug pricing (184)
Drug shortages (25)
Duchenne muscular dystrophy (237)
Earnings (65011)
Editorial (56)
Employer branding (20)
Employer resources (139)
Events (94468)
Executive appointments (999)
FDA (17681)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1418)
Gene editing (209)
Generative AI (45)
Gene therapy (635)
GLP-1 (1003)
Government (4499)
Grass and pollen (7)
Guidances (379)
Healthcare (17315)
HIV (56)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (273)
Immuno-oncology (56)
Indications (100)
Infectious disease (2951)
Inflammatory bowel disease (199)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (243)
Interviews (527)
IPO (14389)
IRA (52)
Job creations (2766)
Job search strategy (1688)
JPM (63)
Kidney cancer (17)
Labor market (62)
Layoffs (551)
Leadership (38)
Legal (6112)
Liver cancer (94)
Longevity (13)
Lung cancer (665)
Lymphoma (366)
Machine learning (40)
Management (52)
Manufacturing (735)
MASH (174)
Medical device (11454)
Medtech (11498)
Mergers & acquisitions (17134)
Metabolic disorders (1289)
Multiple sclerosis (155)
NASH (23)
Neurodegenerative disease (333)
Neuropsychiatric disorders (98)
Neuroscience (3005)
Neurotech (1)
NextGen: Class of 2026 (5988)
Non-profit (4150)
Now hiring (60)
Obesity (604)
Opinion (290)
Ovarian cancer (165)
Pain (201)
Pancreatic cancer (225)
Parkinson's disease (293)
Partnered (32)
Patents (479)
Patient recruitment (471)
Peanut (57)
People (55861)
Pharmaceutical (52)
Pharmacy benefit managers (22)
Phase 1 (21206)
Phase 2 (29775)
Phase 3 (22175)
Pipeline (4996)
Policy (282)
Postmarket research (2393)
Preclinical (8961)
Press Release (60)
Prostate cancer (236)
Psychedelics (54)
Radiopharmaceuticals (288)
Rare diseases (875)
Real estate (4547)
Recruiting (63)
Regulatory (22466)
Reports (30)
Research institute (2339)
Resumes & cover letters (361)
Rett syndrome (28)
RNA editing (21)
RSV (70)
Schizophrenia (156)
Series A (236)
Series B (187)
Service/supplier (3)
Sickle cell disease (100)
Special edition (21)
Spinal muscular atrophy (163)
Sponsored (37)
Startups (3227)
State (2)
Stomach cancer (18)
Supply chain (94)
Tariffs (75)
The Weekly (85)
Vaccines (974)
Venture capital (93)
Weight loss (403)
Women's health (70)
Worklife (19)
Date
Today (206)
Last 7 days (556)
Last 30 days (2305)
Last 365 days (28861)
2026 (2647)
2025 (29097)
2024 (33625)
2023 (37497)
2022 (48413)
2021 (52024)
2020 (50008)
2019 (42544)
2018 (32070)
2017 (29659)
2016 (28193)
2015 (32972)
2014 (25387)
2013 (20574)
2012 (21784)
2011 (22690)
2010 (20430)
Location
Africa (758)
Alabama (84)
Alaska (4)
Arizona (232)
Arkansas (12)
Asia (37804)
Australia (7458)
California (10321)
Canada (3138)
China (1092)
Colorado (427)
Connecticut (413)
Delaware (331)
Europe (85020)
Florida (1551)
Georgia (318)
Hawaii (3)
Idaho (59)
Illinois (784)
India (62)
Indiana (455)
Iowa (18)
Japan (410)
Kansas (116)
Kentucky (33)
Louisiana (25)
Maine (60)
Maryland (1298)
Massachusetts (7525)
Michigan (294)
Minnesota (551)
Mississippi (5)
Missouri (121)
Montana (27)
Nebraska (24)
Nevada (108)
New Hampshire (77)
New Jersey (2860)
New Mexico (26)
New York (2737)
North Carolina (1353)
North Dakota (7)
Northern California (4928)
Ohio (288)
Oklahoma (16)
Oregon (39)
Pennsylvania (2061)
Puerto Rico (22)
Rhode Island (41)
South America (1026)
South Carolina (61)
South Dakota (1)
Southern California (4122)
Tennessee (151)
Texas (1616)
United States (36805)
Utah (320)
Vermont (1)
Virginia (232)
Washington D.C. (71)
Washington State (867)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
620,826 Results for "aquestive therapeutics formerly known as monosolrx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
February 2, 2026
·
15 min read
Press Releases
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
January 9, 2026
·
13 min read
Press Releases
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
November 5, 2025
·
14 min read
Press Releases
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
October 31, 2025
·
5 min read
Press Releases
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
·
3 min read
Press Releases
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
November 4, 2025
·
5 min read
Press Releases
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
October 8, 2025
·
9 min read
Press Releases
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 5, 2025
·
31 min read
Press Releases
Aquestive Therapeutics to Participate in Upcoming September 2025 Investor Conferences
August 26, 2025
·
3 min read
Press Releases
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
August 14, 2025
·
5 min read
1 of 62,083
Next
